ARCHIVES

NCI-Approved Clinical Trials

This article is from The Cancer Letter archive.

Vol. 28 No. 4 | April 29, 2005

Download PDF Visit The Full Archive

Related Articles

NCCN’s First Physician CEO: Robert Carlson Pledges Broader Research and Policy Agenda

October 5, 2012

Connie Mack Joins Washington Office Of Shaw Pittman.

March 2, 2001

Clinical Study Group Proposed To Examine Peer Review System

October 15, 1993

ODAC Recommends Approval Of Paxen; Will IVAX Break Into $1 Billion Market

September 26, 1997

Pediatric Rule Makes FDA Consider Defining Tumors By Molecular Target.

August 31, 2001

In Brief: Zubrod “One Person Who Made The Difference” In Drug Program, DeVita Says in Center’s 25th

July 27, 1984